Metabolic Solutions helps pharmaceutical researchers to use stable isotope (13C, 15N and deuterium) methods through assistance with project design and a comprehensive mass spectrometry service to measure the biological samples resulting from these studies.

In the last 29 years, MSI has provided research services to more than 950 investigators worldwide. We specialize in providing analytical services to the pharmaceutical industry . MSI holds clinical laboratory licenses from both New Hampshire and New York State with a Certificate of Compliance of CLIA Regulations (license #30D0970292). Our laboratory practices and methods are compliant with Food and Drug Administration (FDA) current Good Laboratory Practices (GLP) and Good Clinical Practices (GCP) including Part 11 Compliance. We are a FDA approved GMP facility for Device Manufacturing and Drug Quality Control and last inspected August 2016.